Member Info for PJT12

Has anyone emailed the mainline media outlets or the Huffington Post with this story yet?

Job interviews, I've conducted a few.
1. Research and know about the company you are applying to.
2. Research the job you are applying for. Do not be shy about phoning them (or even asking to spend a bit of time with them) in advance to find out more details about the position as you "want to make sure you are not wasting theirs and your time".
3. Put yourself in their shoes and work out what questions you might ask as the interviewer and, more importantly, what answers you would be looking for.
4. Once prepared and therefore more confident, you have much more chance of being yourself. You cannot do more that that.
5. Good luck with Angle!

Fully expect the new CEO's approach to involve getting a very strong grip through injecting a fairly large dose of "impetus" within the month. Don't see him hanging around as most of what he needs is already in place and his industry contacts should enable him to move pretty quickly in placing the rest. Looking forward to this..........

Sangijuelas1, no offence but if we were to ban everybody we could "see through" on the BB's then there'd hardly be anyone left! At least those on this board seem to have a degree of common sense and most appear able to decide for themselves on the merits or otherwise of the respective posters. If Wyn or anyone else posts something that I strongly disagreed with then I would just try to argue them down. Surely, that's how it works?

Wyn, it's just an opinion and most of us get that. We can ignore it if we don't like it. I think you should continue to contribute as a holder. It's no more likely to affect the SP than the rest of us posting.

@scardey, looking at the SP, as Gary Barlowe would also say, Love Ain't Here Anymore.

@scardey, I'd prefer to see an LFT customer contract that David Wilson had managed to sign-up here to date? I'm sorry but a CV without sales counts for nothing.

Zendog, just don't question the apparent lack of a company "sales team". I raised it a few weeks ago, before certification and PL75 slapped me down, asking me if I expected them to "go round knocking on doors?" Oh, the arrogance and apparent ignorance on here amongst some.

Far be it from me to start a heated debate :) and much as I have time for Wyn and his posts, the biggest problem here, I suspect, will be the charts lack of forecasting capability where unexpected & regular news input which will hopefully be forthcoming on a fairly regular basis in the short to medium term here. That said, I can see how charts could be of interest to those willing to put the effort in.

TopCatz, my apologies for what was a pretty idiotic reply on my part. Point taken from all.

Most on here have done well from AVCT but the communication / predictive skills of AS have left alot to be desired throughout the past year. I do think they will manage to come up with a contract eventually but the lack of anything whatsoever at the time of LFT certification comes as no surprise, moreso in the face of yet more of his numerous 'jam tomorrow' pronouncements of "commercial interest" from many "alleged" parties.

All very positive and I wouldn't argue strongly against any of it. On a separate note, an idea that I saw elsewhere that I really liked was to change the name of the company to Parsortix. That makes alot of sense to me. The more brand familiarisation the better.

Hi Miavoce

Always appreciate your posts and points taken. Truthfully? My speculation is largely based on gut-feeling. In this instance I cannot help but wonder to what extent the FDA approval is already built in? The MM's aren't daft - as we've seen from the three-fold rise, much of which was down to the FDA submission and the recent contract. Those guys always seem to me to be ahead of the game. I can see £3 by next April but we will also need the lab accreditations to have gone smoothly and one additional contract at least. I am well invested here but sincerely look forward to / hope you get to say, 'told ya so' at some stage in the coming weeks. I'll be delighted if I am proved to have been talking out of my hat. Good luck to you and all my fellow investors here.

"from"

And we're supposed to take that advice someone who cannot spell "weak"?

I think the difference is that retail investors / news editors (Most of whom won't even be aware of Parsortix) view there as currently being various options when dealing with cancer whereas there was absolutely nothing on the market for Alzheimers before Biogen. Alzheimers is also a massive socio-economic problem. The upside to this is that those individuals through ignorance and the usual herd laziness provide buying opportunities for those of us who have done our own research. I still think it will be revenue rather than the innovation of it all that will drive ANGLE and draw attention where smaller - but increasingly influential - investors are concerned. We will obviously jump though on FDA approval.

What is a de novo?
• An application sent by the medical device sponsor to FDA

If granted:
Establishes new “device type” along with classification,
regulation, necessary controls and product code

Device is eligible to serve as a predicate (First of its type) for new medical
devices (applying thereafter), where appropriate.

I'd be surprised if we jump to he same extent as Biogen due to their subject matter (Alzheimers) and the fact that they are not on AIM. Also, our platform - amazing as it is - is more complex to understand where retail investors are concerned. What many of them will wrongly have seen is Biogen providing "a cure for Alzheimers", and followed the herd.

For those thinking of investing here and looking for an overview of what brought most of us here, check out the post from "This tea tastes of chicken" on the ADVFN AGL page. I then challenge you not to buy in!!

There's a great post from Bermudashorts today on ADVFN responding to some of today's comments. Just sit on your hands, guys.

Therein lies the dilemna for those looking to trade. Are they willing to gamble that there will not be further contract(s) announced ahead of the FDA announcement. Sit on my hands time for me.